Literature DB >> 17890324

Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma.

Kei Takemoto1, Keiki Ogino, Masafumi Shibamori, Toshikazu Gondo, Yoshiaki Hitomi, Tomoko Takigawa, Da-Hong Wang, Jiro Takaki, Hiroshi Ichimura, Yoshihisa Fujikura, Hironobu Ishiyama.   

Abstract

Changes in the expression of arginase and their association with nitrosative stress were investigated using an asthmatic model previously established in NC/Nga mice with mite extract. Mite crude extract (100 microg/day) from Dermatophagoides farinae was administered intranasally for 5 consecutive days (day 0-4), and a single challenge was performed on day 11. On day 12, upregulation of the mRNA expression of inducible types of nitric oxide synthase (iNOS) and increases in immunohistochemical staining for iNOS and nitrotyrosine were observed. However, the level of nitrite + nitrate was unchanged. An increase in enzymatic activity, upregulation of mRNA expression, and immunostaining for arginase I was detected in the lung tissue and serum. Moreover, increases in both arginase I and II were revealed by immunoblotting. Goblet cell hyperplasia in bronchial epithelial cells and increasing collagen synthesis around the bronchus were also observed. These results suggested that an increase in arginase may lead to decreased availability of arginine for nitric oxide synthase and may contribute to the remodeling of the lung.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890324     DOI: 10.1152/ajplung.00418.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  19 in total

1.  Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?

Authors:  Amir A Zeki; Jennifer M Bratt; Michelle Rabowsky; Jerold A Last; Nicholas J Kenyon
Journal:  Transl Res       Date:  2010-12       Impact factor: 7.012

2.  Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and L-arginine metabolism in mice.

Authors:  Tatsuo Ito; Masayuki Kubo; Kenjiro Nagaoka; Narumi Funakubo; Heri Setiawan; Kei Takemoto; Eri Eguchi; Yoshihisa Fujikura; Keiki Ogino
Journal:  J Physiol Biochem       Date:  2017-11-03       Impact factor: 4.158

3.  Phosphatidylinositol 3-kinase inhibitor suppresses inducible nitric oxide synthase expression in bronchiole epithelial cells in asthmatic rats.

Authors:  Xiaodong Xia; Xiaoguang Hu; Hui Xu; Liqin Wu; Yuanrong Dai; Lei Yang; Zhengjie Xu
Journal:  Mol Cell Biochem       Date:  2011-08-17       Impact factor: 3.396

4.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

5.  Roles of arginase variants, atopy, and ozone in childhood asthma.

Authors:  Muhammad T Salam; Talat Islam; W James Gauderman; Frank D Gilliland
Journal:  J Allergy Clin Immunol       Date:  2009-03       Impact factor: 10.793

Review 6.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

7.  Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.

Authors:  Sandra M Wells; Mary C Buford; Christopher T Migliaccio; Andrij Holian
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-14       Impact factor: 6.914

8.  Anti-inflammatory effect of arginase inhibitor and corticosteroid on airway allergic reactions in a Dermatophogoides farinae-induced NC/Nga mouse model.

Authors:  Keiki Ogino; Masayuki Kubo; Hidekazu Takahashi; Ran Zhang; Yu Zou; Yoshihisa Fujikura
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 9.  Arginase and pulmonary diseases.

Authors:  Harm Maarsingh; Tonio Pera; Herman Meurs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-24       Impact factor: 3.000

10.  Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin.

Authors:  Jennifer M Bratt; Lisa M Franzi; Angela L Linderholm; Erin M O'Roark; Nicholas J Kenyon; Jerold A Last
Journal:  Toxicol Appl Pharmacol       Date:  2009-10-02       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.